Company Filing History:
Years Active: 2000-2004
Title: Innovations of Luis De Lecea
Introduction
Luis De Lecea is a prominent inventor based in Del Mar, California. He has made significant contributions to the field of neuropeptides, particularly in relation to sleep modulation and appetite regulation. With a total of 4 patents, his work has implications for both therapeutic and diagnostic methods.
Latest Patents
One of his latest patents is titled "Antibodies to cortistatin: neuropeptides, compositions and methods." This invention relates to nucleic acids encoding a novel neuropeptide known as cortistatin. The cortistatin nucleic acids, proteins, and polypeptides, along with anti-cortistatin antibodies, are useful in various screening, diagnostic, and therapeutic methods related to sleep modulation and associated disorders. Another significant patent is "Hypothalamus-specific polypeptides," which discloses hypocretin polynucleotides and hypocretin polypeptides. This patent also includes antibodies, oligonucleotides, diagnostic kits, and therapeutic compositions. Hypocretin is localized in the hypothalamus and is involved in appetite and feeding behavior, producing electrical changes in neurons, lowering body temperature, and reducing food intake.
Career Highlights
Luis De Lecea is affiliated with The Scripps Research Institute, where he conducts his research and development. His work has been instrumental in advancing our understanding of neuropeptides and their roles in various physiological processes.
Collaborations
He has collaborated with notable colleagues, including J Gregor Sutcliffe and Steven J Henriksen, contributing to a rich environment of innovation and discovery.
Conclusion
Luis De Lecea's contributions to the field of neuropeptides and his innovative patents highlight his role as a leading inventor in the scientific community. His work continues to pave the way for advancements in therapeutic and diagnostic methods related to sleep and appetite regulation.